Important May 12, 2025 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Geron Corporation Investors of Securities Fraud Class Action Lawsuit
CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:
If you suffered Geron losses, you may CLICK HERE or copy and paste the following link into your browser: https://www.ktmc.com/new-cases/geron-corporation?utm_source=PR&utm_medium=link&utm_campaign=gern&mktm=r
You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected].
DEFENDANTS' ALLEGED MISCONDUCT:
The complaints allege that, throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Defendants created the false impression that they possessed reliable information pertaining to Geron's projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations; (2) in truth, Geron's optimistic reports of its primary product, RYTELO's, launch success and potential growth fell short of reality as the impacts of seasonality, existing competition, and the burden of continued monitoring played a much more significant role in patient starts than Defendants had implied; (3) RYTELO lacked the necessary awareness to penetrate the market, resulting in an inability for Geron to capitalize on the purportedly significant unmet need for the drug, particularly among first-line patients and those outside the academic setting; and (4) as a result, Defendants' statements about the company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
THE LEAD PLAINTIFF PROCESS:
Geron investors may, no later than May 12, 2025, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.
Kessler Topaz Meltzer & Check, LLP encourages Geron investors who have suffered significant losses to contact the firm directly to acquire more information.
CLICK HERE TO SIGN UP FOR THE CASE OR GO TO: https://www.ktmc.com/new-cases/geron-corporation?utm_source=PR&utm_medium=link&utm_campaign=gern&mktm=r
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world. The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.
CONTACT:
Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
[email protected]
May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Meta Platforms, Inc. (META) CEO Mark Zuckerberg Is 'Unbelievable,' Says Jim Cramer
We recently published . Meta Platforms, Inc. (NASDAQ:META) is one of the stocks Jim Cramer recently discussed. Meta Platforms, Inc. (NASDAQ:META) is the largest social media company in the world. Its shares have gained 28% year-to-date on the back of strong advertisement performance and aggressive AI capital expenditure. Cramer is a fan of the firm's smart glasses, and he also believes that Meta Platforms, Inc. (NASDAQ:META) needs to reshape its communications about AI capital expenditure. He heaped praise on the glasses in his latest comments about the firm: 'But I love our tech so much. I just think our tech is really, I mean our tech is equivalent of you know like Zuckerberg. Meta. I mean he's unbelievable. . .I love the sunglasses, I'm bringing them on my trip. . . they, well you can look at a plant and say what is that? What am I looking at? And it works. . . it tells you exactly what it is.' Bloomua / In a recent appearance, Cramer discussed Meta Platforms, Inc. (NASDAQ:META) in detail. Here is what he said: 'Next best, Meta Platforms. I'm agog at the numbers that Mark Zuckerberg's putting up. The most important one, not even talked about on Wall Street enough, 3.5 billion people use at least one Meta product each day. Come on, that's almost half the planet. That's insane. The company's printing money, which is why it can go into the equivalent of free agency and hire incredible talent. It doesn't even matter. You can't even see it in the margins. While we acknowledge the potential of META as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.


Business Wire
8 minutes ago
- Business Wire
Nordson EFD Completes Eighth Job Shadowing Program with Polaris MEP
EAST PROVIDENCE, R.I.--(BUSINESS WIRE)-- Nordson EFD, a Nordson company (NASDAQ: NDSN), announced today it has completed its eighth year of support for the "Fast Track to Advanced Manufacturing" job shadowing program. Hosted by Polaris MEP and the Community College of Rhode Island (CCRI), this is a community-based program in its second year of support for the Jane Addams Resource Corporation (JARC-RI) training center in Providence, RI. The initiative aims to prepare individuals for careers in advanced manufacturing, with job shadowing being a key component of the hands-on experience in workforce training. Nordson EFD has been involved in local internships, facility tours, and hiring local Rhode Island students with the required technical skills for machining and other production jobs. The company partners with Fortune 500 companies and start-ups to solve the many challenges in assembly production with engineered dispensing technology. Polaris-CCRI Internship at Nordson EFD provides job shadowing opportunities and hands-on experience in workforce training. Share According to Polaris MEP, the Rhode Island manufacturing industry is experiencing a skills gap that translates to more available jobs than there are qualified workers. They estimate 3.5 million new skilled manufacturing jobs will be created in the next decade. "Fast Track to CNC Manufacturing" is a full-time 19-week program that introduces the fundamentals of manufacturing, safety, precision measurement and blueprint reading. Nordson EFD hosted 2 trainees from the last cohort as job shadow interns for three days a week, which adds a valuable applied learning component to the students' classroom and workshop education. Nordson EFD's precision fluid dispensing systems are manufactured at its East Providence, RI facility and utilized by various industries including medical device, electronics, and more. "My job shadow experience at Nordson EFD was a pleasant one,' stated Kudirat Aiyedun. 'I worked with engaging employees on the manufacturing floor who were all helpful and friendly. Some employees also helped me with ideas and training for my final project, which was Solid Works - ENGR 1030. I was instructed on how to read blueprints and operation sheets, as well as the use of a height gage, a micrometer and calipers. I was also taught how to set up a CNC milling machine during my internship. I enjoyed my time at Nordson EFD." "Nordson EFD has been an important employer partner since the inception of the program. They've opened their doors to our trainees, giving them hands on experience through job-shadowing opportunities,' states Aarin B. Clemons, Workforce Manager at Polaris MEP. 'We were among the first companies in Rhode Island to sign up with Polaris MEP to host and hire students participating in this mentorship program that prepares individuals for entry-level positions such as machinists/toolmakers and CNC operators,' states Scott Menko, Director of Operations, Nordson EFD. 'Job shadowing with industry professionals builds skills through practical learning, as students observe how tasks are performed in a real-world manufacturing environment. The networking aspect of the experience gives employers the opportunity to meet and nurture fresh talent with the potential to be hired after graduation.' About Nordson EFD Nordson EFD designs and manufactures precision fluid dispensing systems for benchtop assembly processes and automated assembly lines. By enabling manufacturers to accurately and consistently apply the same amount of assembly fluid to every part, EFD helps customers improve process control and throughput. In addition to producing high-quality fluid packaging syringe and cartridge systems, the company is also a leading formulator of specialty solder pastes for dispensing and printing applications. Nordson EFD is at the forefront of introducing Industry 4.0 efficiencies to the micro-dispensing marketplace, adding a new level of control and connectivity to its micro-dispensing solutions. Serving a wide variety of industries for more than 60 years, Nordson EFD has offices, application laboratories and technical support staff in 30 countries worldwide. To learn more, visit and follow us at About Nordson Corporation Nordson engineers, manufactures, and markets differentiated products and systems used for dispensing and processing adhesives, coatings, polymers, sealants and biomaterials; and for managing fluids, testing and inspecting for quality, treating surfaces and curing. These products are supported with extensive application expertise and direct global sales and service. We serve a wide variety of consumer non-durable, consumer durable and technology end markets including packaging, nonwovens, electronics, medical, appliances, energy, transportation, building and construction, and general product assembly and finishing. Founded in 1954 and headquartered in Westlake, Ohio, the company has operations and support offices in more than 30 countries. Visit Nordson on the web at

Yahoo
8 minutes ago
- Yahoo
BofA downgrades Novavax stock on vaccine uncertainty
-- Bank of America cut its rating on Novavax (NASDAQ:NVAX) to Underperform from Neutral and lowered its price objective to $7 from $9, saying recent gains in the shares have overrun a still uncertain outlook for the company's COVID-19 and flu vaccine programs. Analysts said that while Novavax has executed well on cost cutting and operational cleanup, they see limited revenue upside near term. They noted that commercialization of its COVID vaccine Nuvaxovid by partner Sanofi (NASDAQ:SNY) may be slow due to a restrictive U.S. label and fading pandemic demand. The bank also said new FDA guidelines could make it harder and costlier for Novavax to sign new partners for its combined COVID/flu vaccine program. BofA forecasts slowing overall revenue, estimating about $1 billion in 2025, slightly below the company's guidance. It expects longer-term COVID sales to taper as variant shifts require more studies, and cut its peak market share estimate for Nuvaxovid to 14% from 18%. The analysts said the company's vaccine platform still has potential but requires more external validation, with platform licensing or partnership deals representing the main upside risk to their view. COVID opportunity is largely priced in, according to analysts warning that consensus revenue estimates may still be too high for the coming two years. Novavax shares had risen recently as funding cuts hit mRNA competitors, but BofA said that tailwind now looks temporary Related articles BofA downgrades Novavax stock on vaccine uncertainty Victoria's Secret Exposed: The Warning Sign Behind the Stock's 52% Collapse Risks Rising? Smart Money Dodged 46%+ Drawdowns on These High-Flying Names Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data